Skip to main content
. 2015 Mar 30;6(16):14374–14384. doi: 10.18632/oncotarget.3720

Figure 1. Expression of CD22 in CTCL cell lines.

Figure 1

A. RT-PCR analysis of CD22 expression using primers amplifying exon 11-14 region of CD22, B. Western blot analysis of CD22 protein expression using FPC1 anti-CD22 mAb, C. and D. Flow cytometry analysis of CD22 cell surface expression using PE-conjugated anti-CD22 mAbs (S-HCL-1, RFB-4) or unconjugated anti-CD22 mAbs (RFB-4, FR10B4) followed by PE-conjugated secondary antibody (rabbit anti-mouse F(ab')2).